Back to Search Start Over

MeCP2 as an Activator of Gene Expression.

Authors :
Horvath PM
Monteggia LM
Source :
Trends in neurosciences [Trends Neurosci] 2018 Feb; Vol. 41 (2), pp. 72-74.
Publication Year :
2018

Abstract

Rett syndrome is a neurodevelopmental disorder that primarily affects females and is caused by mutations in the methyl-CpG-binding-protein 2 (MECP2) gene. Initially, MeCP2 had been shown to be a repressor of gene transcription. In their 2008 paper, Chahrour and colleagues (DOI: 10.1126/science.1153252) reported that MeCP2 could also function as a transcriptional activator.<br /> (Copyright © 2017 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1878-108X
Volume :
41
Issue :
2
Database :
MEDLINE
Journal :
Trends in neurosciences
Publication Type :
Academic Journal
Accession number :
29405930
Full Text :
https://doi.org/10.1016/j.tins.2017.11.005